HomeNewsTrendsIndia’s largest COVID-19 facility in Delhi to have 10 times the capacity of China's biggest centre

India’s largest COVID-19 facility in Delhi to have 10 times the capacity of China's biggest centre

The deadline to make the first 2,000 of the 10,200 beds available at Delhi's new COVID-19 facility is June 25. The remaining beds are likely to be arranged by July 3

June 23, 2020 / 19:15 IST
Story continues below Advertisement

India’s biggest COVID-19 facility, nearly ten times that of China’s Leishenshan facility, is set to open this week in South Delhi. It is as large as 15 football fields and can accommodate more than 10,000 coronavirus patients at a time, according to a Hindustan Times report.

Story continues below Advertisement

“This would be 10 times bigger than the temporary field facility that was set up for novel coronavirus patients in China’s Leishenshan, which could accommodate 1,000 patients,” the report stated quoting a senior Home Ministry official.

The facility located in Chattarpur area will be run by medical personnel from the Indo-Tibetan Border Police (ITBP). It has been named the Sardar Patel COVID Care Centre and Hospital,

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show